HOSPIRA, INC. $500,000,000 5.600% Notes Due 2040 UNDERWRITING AGREEMENTUnderwriting Agreement • September 10th, 2010 • Hospira Inc • Pharmaceutical preparations • New York
The opinion of Mayer Brown LLP, outside counsel for the Company, to be delivered pursuant to Section 5(c) of Underwriting Agreement, shall be to the effect that:
